Pulse Biosciences, Inc. Debt Securities, Available-for-sale, Unrealized Gain (Loss)
Pulse Biosciences, Inc. (PLSE) reported Debt Securities, Available-for-sale, Unrealized Gain (Loss) of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-31.
Discontinued › Income Statement › Other Income
us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss · last filed 2023-03-31
- Pulse Biosciences, Inc. debt securities, available-for-sale, unrealized gain (loss) for the quarter ending 2021-12-31 was $0.00.
- Pulse Biosciences, Inc. debt securities, available-for-sale, unrealized gain (loss) for the quarter ending 2021-09-30 was $0.00.
- Pulse Biosciences, Inc. debt securities, available-for-sale, unrealized gain (loss) for the quarter ending 2021-06-30 was $0.00.
- Pulse Biosciences, Inc. debt securities, available-for-sale, unrealized gain (loss) for the quarter ending 2021-03-31 was $1.00K.
- Pulse Biosciences, Inc. debt securities, available-for-sale, unrealized gain (loss) for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- Pulse Biosciences, Inc. debt securities, available-for-sale, unrealized gain (loss) for fiscal 2021 was $1.00K.
- Pulse Biosciences, Inc. debt securities, available-for-sale, unrealized gain (loss) for fiscal 2020 was -$5.00K, a 200.00% decline from fiscal 2019.
- Pulse Biosciences, Inc. debt securities, available-for-sale, unrealized gain (loss) for fiscal 2019 was $5.00K.
| Period end | Debt Securities, Available-for-sale, Unrealized Gain (Loss) 3 month | Debt Securities, Available-for-sale, Unrealized Gain (Loss) 6 month | Debt Securities, Available-for-sale, Unrealized Gain (Loss) 9 month | Debt Securities, Available-for-sale, Unrealized Gain (Loss) 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-03-31 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $0.00 derived: sum of 2 quarters · filed 2023-03-31 | $0.00 derived: sum of 3 quarters · filed 2023-03-31 | $1.00K 10-K · filed 2023-03-31 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $0.00 derived: sum of 2 quarters · filed 2022-11-10 | $1.00K 10-Q · filed 2022-11-10 | -$1.00K derived: sum of 4 quarters · filed 2023-03-31 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $1.00K 10-Q · filed 2022-08-10 | -$1.00K derived: sum of 3 quarters · filed 2023-03-31 | |
| 2021-03-31 | $1.00K 10-Q · filed 2022-05-11 | -$1.00K derived: sum of 2 quarters · filed 2023-03-31 | ||
| 2020-12-31 | -$2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$5.00K 10-K · filed 2023-03-31 | ||
| 2020-09-30 | -$3.00K 10-Q · filed 2021-11-15 | |||
| 2019-12-31 | $5.00K 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |